BioLife Solutions, Inc.

BioLife Solutions, Inc.

BLFS
BioLife Solutions, Inc.US flagNASDAQ Capital Market
26.10
USD
-0.50
- -
1.28BMarket Cap

Total Valuation

BioLife Solutions, Inc. carries a market capitalization of 1.28B, placing it among publicly traded companies globally. Its enterprise value stands at 851.26M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap1.28B
Enterprise Value851.26M

Share Statistics

BioLife Solutions, Inc. currently has 48.83M shares outstanding.

Shares Outstanding48.83M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 9.19, and the price-to-book ratio stands at -2.71.

PE RatioN/A
PS Ratio9.19
PB Ratio-2.71
P/TBV Ratio5.74
P/FCF Ratio33.95
P/OCF Ratio51.26

Enterprise Valuation

EV / Sales8.53
EV / EBITDAN/A
EV / EBITN/A
EV / FCF31.11

Financial Position

BioLife Solutions, Inc. maintains a current ratio of 7.30, meaning it holds 7.3x the short-term assets needed to cover near-term liabilities.

Current Ratio7.30
Quick Ratio5.15
Debt / Equity3.99
Debt / EBITDA-1.31
Interest CoverageN/A

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-0.74
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)1.94
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover1.19

Taxes

Over the trailing twelve months, BioLife Solutions, Inc. has paid 97,000.00 in income taxes, reflecting an effective tax rate of 16.63.

Income Tax97,000.00
Effective Tax Rate16.63

Stock Price Statistics

BioLife Solutions, Inc.'s stock has gained approximately 17.09287% over the past 52 weeks. The 50-day moving average sits at 22.74, while the 200-day moving average is 23.96.

Beta (5Y)N/A
52-Week Price Change17.09287%
50-Day Moving Average22.74
200-Day Moving Average23.96
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, BioLife Solutions, Inc. generated 99.77M in revenue and converted that into -2.96M in net income, yielding earnings per share of -0.22. EBITDA reached -11.36M, while operating income came in at -15.36M.

Revenue99.77M
Gross Profit63.83M
Operating Income-15.36M
Pretax Income-10.40M
Net Income-2.96M
EBITDA-11.36M
EBIT-15.36M
Earnings Per Share (EPS)-0.22

Balance Sheet

BioLife Solutions, Inc. holds 81.00M in cash and equivalents against 14.86M in total debt, resulting in a net debt position of -20.32M. Total book value stands at -338.46M, with working capital of 114.97M providing operational flexibility.

Cash & Cash Equivalents81.00M
Total Debt14.86M
Net Debt-20.32M
Equity (Book Value)-338.46M
Book Value Per Share-7.04
Working Capital114.97M

Cash Flow

BioLife Solutions, Inc. produced 17.90M in operating cash flow over the past twelve months. After subtracting -9.47M in capital expenditures, free cash flow totaled 8.43M - equivalent to 0.18 per share.

Operating Cash Flow17.90M
Capital Expenditures-9.47M
Free Cash Flow8.43M
FCF Per Share0.18

Margins

BioLife Solutions, Inc. operates with a gross margin of 63.97, reflecting its pricing power and cost economics. The operating margin of -15.39 and net profit margin of -2.97 provide insight into operational efficiency.

Gross Margin63.97
Operating Margin-15.39
Pretax Margin-10.42
Profit Margin-2.97
EBITDA Margin-11.38

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield1.73
FCF Yield2.95

Stock Splits

BioLife Solutions, Inc.'s most recent stock split took place on January 29, 2014 with a 14:1 split ratio.

Last Split Date1/29/2014
Split Ratio14:1

Scores

BioLife Solutions, Inc. posts an Altman Z-Score of 17.67, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score17.67